Bio/Pharmaceutical Analysis Techniques

Laboratory Equipment and Instruments

Analytics

Deals, Development and Manufacturing

Inhalation Drugs

Parenterals and Injectables

Solid/Semi-Solid Dosage

Specialty Dosage Drugs

Dosage Forms

APIs and Excipients

Formulation and Drug Delivery

Ingredients

Intellectual Property and Patents

Process and Scaling

Drug Development

Global Perspectives

Intellectual Property & Patents

Aseptic/Sterile Processing

Data and Artificial Intelligence

Equipment

Manufacturing, Biologic Drugs

Manufacturing, Biosimilars and Biobetters

Manufacturing, Cell Therapies

Manufacturing, Gene Therapies

Manufacturing, Inhalation Drugs

Manufacturing, Parenterals and Injectables

Manufacturing, Solid and Semi-Solid Dosage Drugs

Packaging and Distribution

Process and Automation

Supply Chain

Manufacturing

Mergers and Acquisitions

Contract Analytical Services

Contract Development Services

Contract Manufacturing, General

Contract Research Services

Logistics and Distribution

Regulatory Consulting

Outsourcing

Quality Assurance/Quality Control

Regulatory Oversight

Regulatory Oversight and Compliance

Quality Systems

News

Business

Bio/Pharma Business

All News

Top News

Industry News

Bio/Pharma News

Supplier News

News from Europe

Publications

All Publications

PharmTech

PharmTech Europe

Resources

Marketplace

Front & Center

ICH Q9 Revision: A Comprehensive Resource on Quality Risk Management

Peer-Reviewed Research

PharmTech Products

Pharma Insights

Whitepapers

Webcasts

Multimedia

All Videos

Ask the Expert

Behind The Headlines

Buy, Sell, Hold

Drug Digest Videos

Drug Solutions Podcast

Peer Exchange

Sexy Science

Tech Talk

Conference

Conference Coverage

Conference Listing

Events

Subscribe

Pharmaceutical Technology is the independent source for information, insight, and analysis on bio/pharmaceutical formulation, development, and manufacturing.

About Us

Advertise

Contact Us

Editorial Info

Editorial Advisory Board

Do Not Sell My Personal Information

Privacy Policy

Terms and Conditions

Pharmaceutical Technology

Twitter

LinkedIn

Spotlight

Topic

COVID-19 Update

APIs

Analytical Method Development

Aseptic Processing

Biologic Drugs

Drug Delivery

Excipients

Formulation

Packaging

Process Control/PAT

Process Development

QA/QC

Regulatory Action

1rem

On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States. 

Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact

Winners are selected entirely through industry voting, with those honored representing recognition by their peers.

Novotech Named Best Australian CRO at Asia-Pacific Biopharma Excellence Awards

C3TI will promote CDER’s clinical trial innovation activities both internally and externally.

FDA Establishes Center for Clinical Trial Innovation

There are considerations companies may want to consider before seeking out a service provider.

Taking Full Advantage of Service Providers

The need for preclinical testing expertise is growing as molecular complexity increases.

Navigating the Preclinical CRO Outsourcing Process

Industry Outlook for 2025—Real World Data

The use of real-world data (RWD) and real-world evidence (RWE) has become a focus of pharmaceutical regulators in recent years. In December 2024, FDA’s Center for Drug Evaluation and Research announced a new Center for Real-World Evidence Innovation that will coordinate and promote the use of these data in regulatory decision making (1). The agency also published a number of guidance documents on data in 2023 and 2024 (2,3). The European Medicines Agency is also working to promote the use of RWD and RWE (4).

To gain more perspective on these data and other trends impacting the industry, 

® spoke with Sujay Jadhav, CEO of Verana Health. “We're seeing exponential changes in both of those particular components,” says Jadhav. “[F]rom an approach perspective, particularly in clinical research, we're seeing sort of external control arms becoming more mainstream. Part of [this is because] of [FDA] and their guidance of late, which [is about] helping facilitate the leveraging of real-world data and external control arms in the overall drug discovery process. But a key component is that this is an incredible source to help improve sort of efficiency and the quality of our research overall.”

“One of the other trends that we are also seeing is predictive analytics and AI [artificial intelligence], and how this can help predict disease progression and assist with early detection to support patient recruitment and retention … AI and these technologies, they can identify trends for data, [and lead to] informed decisions across the drug life cycle.”

Click the above video to watch the interview.

1. Haigney, S. FDA Creates CDER Center for Real-World Evidence Innovation. 

Guidance for Industry, Data Standards for Drug and Biological Product Submissions Containing Real-World Data

Guidance for Industry, Real-World Data: Assessing Electronic Health Records and Medical Claims Data to Support Regulatory Decision-Making for Drug and Biological Products

 (CDER, CBER, July 2024).
4. Barton, C. Using RWD in Non-Interventional Studies. 

Videos

Pharmaceutical Technology® spoke with Sujay Jadhav, CEO of Verana Health about trends in real-world data and the impact these trends will continue to have on the pharmaceutical industry in 2025.

Industry Outlook for 2025—Real-World Data

Contract Research Services

Latest News